Literature DB >> 7683778

Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterization.

C J Allen1, J R Ghilardi, S R Vigna, P J Mannon, I L Taylor, D C McVey, J E Maggio, P W Mantyh.   

Abstract

[125I]Peptide YY was used to localize and characterize peptide YY and neuropeptide Y receptor binding sites in the heart. In the rat and rabbit heart, nearly every artery and arteriole that could be histologically identified also expressed saturable binding sites for [125I]peptide YY. In the arteries, these [125I]peptide YY binding sites were primarily associated with the smooth muscle layer. Pharmacological experiments demonstrated that peptide YY and neuropeptide Y were equipotent in competing for [125I]peptide YY binding in the heart. In another competition series, [Leu31,Pro34]-neuropeptide Y (a Y1 receptor-specific agonist when used with [125I]peptide YY) was significantly more potent than neuropeptide Y (a Y2 receptor-specific agonist when used with [125I]peptide YY) in competing for [125I]peptide YY binding from coronary arteries, suggesting that the receptor binding sites on cardiac arteries and arterioles are of the Y1 subtype. These results demonstrate that smooth muscle cells of the atrial and ventricular arteries and arterioles in rat and rabbit heart express Y1 receptors and suggest a possible direct effect of neuropeptide Y on coronary blood vessels to induce vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683778     DOI: 10.1016/0306-4522(93)90633-q

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

1.  Localization of neuropeptide Y Y1 receptors in cerebral blood vessels.

Authors:  L Bao; J Kopp; X Zhang; Z Q Xu; L F Zhang; H Wong; J Walsh; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

2.  Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.

Authors:  A P Serone; C E Wright; J A Angus
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery.

Authors:  Ursula Hanusch-Enserer; Mohammed A Ghatei; Edmund Cauza; Steven R Bloom; Rudolf Prager; Michael Roden
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Inositol hexakisphosphate binding sites in rat heart and brain.

Authors:  K G Rowley; A L Gundlach; M Cincotta; W J Louis
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.